Sanara MedTech Inc. is a medical technology company that develops and commercializes surgical and chronic wound care products. Based in Fort Worth, Texas, the company provides biologic and antimicrobial solutions, such as collagen-based powders and wound cleansers, to hospitals and ambulatory surgical centers. The company's flagship product line includes CellerateRX Surgical, an activated collagen adjuvant used to support healing in surgical sites. Its broader portfolio features BIAKOS antimicrobial skin and wound cleansers, BIASURGE surgical irrigation solutions, and HemaQuell, a resorbable bone hemostat. Operating primarily in North America, Sanara utilizes a direct sales force and distributor network to market its disposable medical supplies to healthcare facilities. In late 2025, the company strategically realigned its operations to focus exclusively on its core surgical business, discontinuing its Tissue Health Plus segment.
